Grants and Contributions

The objectives of this funding opportunity are to fund new research that will improve health and achieve more equitable outcomes in nutrition, metabolic health and chronic high burden diseases, as well as STBBI, across the life course of diverse groups of people in Canada by:

1. Developing precision medicine approaches to characterize the variability that underlies mechanisms of disease, to prevent, detect and intervene effectively in terms of disease susceptibility, progression, resilience and reversibility, and treatment
2. Increasing our understanding of interactions between structural, social, environmental, and biological determinants of health in Indigenous communities that underlie heterogeneity in health and disease
3. Increasing our understanding of interactions between structural, social, environmental, and biological determinants of health with particular emphasis on a diversity of populations who have historically experienced inequitable outcomes in Canada and at-risk groups that underlie heterogeneity in health and disease

Note that applicants will not be required to meet all the objectives in their respective application, but all objectives will be met through the funding opportunity.

The objectives of this funding opportunity are to fund new research that will improve health and achieve more equitable outcomes in nutrition, metabolic health and chronic high burden diseases, as well as STBBI, across the life course of diverse groups of people in Canada by:

1. Developing precision medicine approaches to characterize the variability that underlies mechanisms of disease, to prevent, detect and intervene effectively in terms of disease susceptibility, progression, resilience and reversibility, and treatment
2. Increasing our understanding of interactions between structural, social, environmental, and biological determinants of health in Indigenous communities that underlie heterogeneity in health and disease
3. Increasing our understanding of interactions between structural, social, environmental, and biological determinants of health with particular emphasis on a diversity of populations who have historically experienced inequitable outcomes in Canada and at-risk groups that underlie heterogeneity in health and disease

Note that applicants will not be required to meet all the objectives in their respective application, but all objectives will be met through the funding opportunity.

Funding Pool of EDL; related codes EL0-EL9

The objectives of this funding opportunity are to fund new research that will improve health and achieve more equitable outcomes in nutrition, metabolic health and chronic high burden diseases, as well as STBBI, across the life course of diverse groups of people in Canada by:

1. Developing precision medicine approaches to characterize the variability that underlies mechanisms of disease, to prevent, detect and intervene effectively in terms of disease susceptibility, progression, resilience and reversibility, and treatment
2. Increasing our understanding of interactions between structural, social, environmental, and biological determinants of health in Indigenous communities that underlie heterogeneity in health and disease
3. Increasing our understanding of interactions between structural, social, environmental, and biological determinants of health with particular emphasis on a diversity of populations who have historically experienced inequitable outcomes in Canada and at-risk groups that underlie heterogeneity in health and disease

Note that applicants will not be required to meet all the objectives in their respective application, but all objectives will be met through the funding opportunity.

The objectives of this funding opportunity are to fund new research that will improve health and achieve more equitable outcomes in nutrition, metabolic health and chronic high burden diseases, as well as STBBI, across the life course of diverse groups of people in Canada by:

1. Developing precision medicine approaches to characterize the variability that underlies mechanisms of disease, to prevent, detect and intervene effectively in terms of disease susceptibility, progression, resilience and reversibility, and treatment
2. Increasing our understanding of interactions between structural, social, environmental, and biological determinants of health in Indigenous communities that underlie heterogeneity in health and disease
3. Increasing our understanding of interactions between structural, social, environmental, and biological determinants of health with particular emphasis on a diversity of populations who have historically experienced inequitable outcomes in Canada and at-risk groups that underlie heterogeneity in health and disease

Note that applicants will not be required to meet all the objectives in their respective application, but all objectives will be met through the funding opportunity.

The objectives of this funding opportunity are to fund new research that will improve health and achieve more equitable outcomes in nutrition, metabolic health and chronic high burden diseases, as well as STBBI, across the life course of diverse groups of people in Canada by:

1. Developing precision medicine approaches to characterize the variability that underlies mechanisms of disease, to prevent, detect and intervene effectively in terms of disease susceptibility, progression, resilience and reversibility, and treatment
2. Increasing our understanding of interactions between structural, social, environmental, and biological determinants of health in Indigenous communities that underlie heterogeneity in health and disease
3. Increasing our understanding of interactions between structural, social, environmental, and biological determinants of health with particular emphasis on a diversity of populations who have historically experienced inequitable outcomes in Canada and at-risk groups that underlie heterogeneity in health and disease

Note that applicants will not be required to meet all the objectives in their respective application, but all objectives will be met through the funding opportunity.

The specific objective(s) of this funding opportunity are to:

· Strengthen national vaccine research, using an inclusive approach, by undertaking and coordinating collaborative multidisciplinary research amongst vaccine and immunization researchers, clinicians, public health professionals, and local, provincial, territorial and federal policy-makers with relevant mandates for public health and healthcare systems, across all research areas;
· Strengthen Canada’s state of readiness by building and enhancing capacities, processes, and expertise to provide a rapid, priority-driven, vaccine research response to infectious public health events with actual or potential significant negative impacts to the health of people in Canada;
· Strengthen capacities, processes, and expertise to undertake clinical trials of vaccine candidates for vaccine-preventable diseases in alignment with domestic and global vaccine clinical trial strategies;
· Increase the availability of high-quality and real-time evidence, and improve data-sharing and knowledge mobilization with local, provincial, territorial, national and international knowledge users, in both official languages, to ensure maximum research impact to improve the health of all people in Canada; and
· Train and support the diverse next generation of vaccine and immunization researchers.

As a component of Canada’s Biomanufacturing and Life Sciences Strategy, this funding opportunity shares the same objectives, namely:

• To better prepare Canada to respond to pandemics and other health emergencies; and
• To support an innovative, high growth domestic life sciences sector.

As a component of Canada’s Biomanufacturing and Life Sciences Strategy, this funding opportunity shares the same objectives, namely:

• To better prepare Canada to respond to pandemics and other health emergencies; and
• To support an innovative, high growth domestic life sciences sector.

The ICS Program is designed to foster community development by providing grants and awards to individuals and organizations for the purposes of:

• Enabling research and knowledge translation activities where the circumstances fall outside of CIHR's current suite of funding programs.

• Supporting individuals and organizations whose goals are consistent with CIHR and its Institutes' vision, mandate and strategic directions.

The ICS Program is not intended to support the direct cost of research (e.g., pilot projects, feasibility studies or operating grants), principal and co-investigator salaries or research equipment.

As a component of Canada’s Biomanufacturing and Life Sciences Strategy, this funding opportunity shares the same objectives, namely:

• To better prepare Canada to respond to pandemics and other health emergencies; and
• To support an innovative, high growth domestic life sciences sector.